Clinical trial
Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent…
NCT00417573 · The Center for Rheumatic Disease, Allergy, & Immunology, Other · Completed
Key facts
| NCT number | NCT00417573 |
|---|---|
| Title | Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections |
| Official title | Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections |
| Lead sponsor | The Center for Rheumatic Disease, Allergy, & Immunology, Other |
| Collaborators | Grifols Therapeutics LLC Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | IgG Deficiency, Infections |
| Intervention type | Drug |
| Interventions | IV Gamunex 10% |
| Enrollment | 10 |
| Start date | Dec 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Jan 1, 2007 |
| Last update posted | Jan 1, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: